Spore.Bio
Spore.Bio is a DeepTech company developing a new generation of microbiological detection devices. Bacterial contamination is a rising threat for Food&Beverage, Pharma and Cosmetics manufacturers. The weapons they have to fight these threats are long, constraintful and painful to use. Spore.Bio is solving this pain by combining advanced photonics and Machine Learning to detect bacteria within a few seconds.
Major scandals recently rocked the Food & Beverage sector all around the world, because of bacteriological contamination in food products. Every year, 800 food recalls are registered only in the US, costing approximately $10 million per recall. Conventional bacterial detection methods, such as Petri dish and PCR-based tests, take on average five days to produce results, which does not help manufacturers to correctly assess contamination risks.
Spore.Bio are developing the first instantaneous pathogen detection device that is directly usable on the shopfloor, combining cutting-edge optical solution with advanced machine learning models. Within six months, Spore.Bio developed their first functional prototype in their lab, and are already implementing it on the shopfloor with their first customers.
Founders
Amine Raji
CEO
Amine holds a degree in Physics from Lycee Janson-de-Sailly, and a Master’s degree at ParisTech in Industrial and Mechanical Engineering. His career took him to Nestlé, where he specialized in project engineering.
Maxime Mistretta
CTO
Maxime holds a PhD & Postdoc in Microbiology from Institut Pasteur, following a Master’s degree in Biology from UTC. He spent many years in advanced research labs looking at bacterial science.
Mohamed Tazi
COO
Mohamed began his career at Deloitte in the Audit department. In 2013, he built his first start up, Gymlib, which he sold in 2022.
Milestones
Founded at Entrepreneurs First
Pre-Seed (€8 million) led by LocalGlobe
Series A ($23 million) led by Singular